GlassScriptPhysician profile
Rusheena Bartlett
NPI 1427581123
$5,808.97
in general payments reported to CMS, 2019-2025
21 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.07 · 2020: $100 · 2021: $1,273 · 2022: $2,058 · 2023: $459 · 2024: $753 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,240.00 | 2021 | |
| Southern Edge Orthopaedics, INC. | $1,200.00 | 2022 | |
| Biotissue Holdings INC. | $773.85 | 2022-2025 | |
| Stryker Corporation | $680.82 | 2020-2025 | Infinity Adaptis, Prophecy, Augment Injectable |
| Paratek Pharmaceuticals, INC. | $274.60 | 2023-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $251.22 | 2024-2025 | |
| Amgen INC. | $219.15 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $210.47 | 2022 | |
| Integra Lifesciences Corporation | $192.81 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $174.07 | 2023-2024 | Senza |
| Aroa Biosurgery Incorporated | $122.17 | 2025 | |
| Smith+Nephew, INC. | $89.69 | 2021-2025 | Stravix Pl, Grafix Pl |
| Trice Medical, INC. | $75.54 | 2025 | |
| Hnm Stainless, LLC | $55.00 | 2023 | |
| Hologic Sales and Service, LLC | $53.38 | 2024 | Aptima |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $34.90 | 2025 | Senza |
| Convatec INC. | $33.87 | 2024 | |
| Dexcom, INC. | $33.40 | 2024 | Dexcom G6 Transmitter |
| Mallinckrodt Hospital Products INC. | $31.75 | 2025 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $29.83 | 2023 | |
| Abbott Laboratories | $20.38 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rusheena Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.